Chirag Sachar

Chirag Sachar is a dedicated professional currently contributing to the Immunai Business Development team, focusing on leveraging machine learning to advance Immuno-oncology therapies. His academic journey includes a Ph.D. in Biomedical Engineering from Columbia University, where his research was centered around engineering the immune system and studying T cell mechanobiology. Chirag has a strong passion for translating scientific innovations into practical clinical solutions.

Chirag Sachar's educational background is quite extensive, including a Doctor of Philosophy (Ph.D.) and a Master of Science (MS) in Biomedical/Medical Engineering from Columbia University in the City of New York. He also pursued a Bachelor's degree in Biology & Molecular Engineering at The University of Chicago, further enhancing his interdisciplinary knowledge. Additionally, Chirag holds a Master of Philosophy (MPhil) in Biomedical/Medical Engineering from Columbia University.

In terms of professional experience, Chirag Sachar has been affiliated with various esteemed organizations. He has served as the Scientific Alliance and Partner Manager at Immunai, showcasing his expertise in fostering collaborations and managing scientific initiatives. Chirag has also contributed as a Guest Lecturer in Biomedical Engineering at Columbia University, sharing his wealth of knowledge with aspiring students. Furthermore, he has worked as a Consulting Expert at DOAR, Inc., demonstrating his consulting abilities in the field. Chirag also has experience as a Project Manager at Columbia Biomedical Technology Accelerator (BiomedX) at Columbia University and as a Venture Fellow at Fission Ventures, highlighting his diverse skill set and interests.

Chirag Sachar's professional journey includes roles such as a PHD Candidate, R&D Engineering Intern, and Teaching Assistant at reputable institutions like Columbia University and the University of Chicago. He has also been involved in impactful research projects, including positions at the Rehabilitation Institute of Chicago and the Pritzker School of Medicine at the University of Chicago. Chirag's commitment to professional growth is evident through his Engineering Internship at Johnson Medtech, where he gained valuable industry experience.

Overall, Chirag Sachar is a motivated individual with a strong academic foundation and a wealth of professional experiences in biomedical engineering and scientific collaboration. His enthusiasm for advancing Immuno-oncology therapies through innovative technologies and clinical applications sets him apart as a valuable asset in the field.